Safety Shot publishes peer-reviewed trial showing rapid alcohol reduction and hangover prevention

BONK, INC.

Randomized, double-blind, placebo-controlled crossover study published in Journal of Nutrition and Dietary Supplements (Volume 17, Pages 43-62).
Safety Shot significantly reduced blood and breath alcohol levels at 30-240 minutes post-consumption (p<0.05).
Increased aldehyde dehydrogenase (AUC and Cmax both p<0.01), suggesting faster alcohol metabolism.
Participants reported less head discomfort, fatigue, and improved concentration vs placebo.
Company cites global hangover cure market projected to reach over $6B by 2032 at 14.1% CAGR.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.